First malaria drug for newborns and young infants cleared A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young children.

A new formulation of #Novartis' #antimalarial #Coartem has become the first medicine to be approved for use in very young #children who contract the potentially deadly #mosquito-borne disease.

pharmaphorum.com/news/first-m...